45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
8,899
Insurances with rates
19
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 06118200_1 | INJECTION, IPILIMUMAB, 1 MG | $127,831 | $108,657 | — | — | 24 |
| 06118275_1 | INJECTION, OCRELIZUMAB, 1 MG | $74,308 | $63,161 | — | — | 24 |
| 04863685_1 | Insertion or replacement of spinal neurostimulator generator or receiver | $74,043 | $62,936 | — | — | 24 |
| 06118271_1 | INJECTION, TILDRAKIZUMAB, 1 MG | $64,662 | $54,963 | — | — | 24 |
| 06118328_1 | UNCLASSIFIED BIOLOGICS | $54,000 | $45,900 | — | — | 24 |
| 06118296_1 | INJECTION, NIVOLUMAB AND RELATLIMAB-RMBW, 3 MG/1 MG | $52,317 | $44,469 | — | — | 24 |
| 06118160_1 | INJECTION, CABAZITAXEL, 1 MG | $48,475 | $41,203 | — | — | 24 |
| 06118222_1 | LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG | $44,153 | $37,530 | — | — | 24 |
| 06118265_1 | INJECTION, LUSPATERCEPT-AAMT, 0.25 MG | $43,551 | $37,018 | — | — | 24 |
| 04862362_1 | Insertion of programmable spinal canal drug infusion pump | $42,525 | $36,146 | — | — | 24 |
| 06118262_1 | INJECTION, BRENTUXIMAB VEDOTIN, 1 MG | $40,688 | $34,585 | — | — | 24 |
| 06118195_1 | INJECTION, ATEZOLIZUMAB, 10 MG | $38,181 | $32,454 | — | — | 24 |
| 06118279_1 | INJECTION, DARATUMUMAB, 10 MG AND HYALURONIDASE-FIHJ | $38,059 | $32,350 | — | — | 24 |
| 06118288_1 | INJECTION, CEMIPLIMAB-RWLC, 1 MG | $35,992 | $30,594 | — | — | 24 |
| 06118254_1 | INJECTION, RITUXIMAB 10 MG AND HYALURONIDASE | $35,514 | $30,187 | — | — | 24 |
| 06118315_1 | INJECTION, RISANKIZUMAB-RZAA, INTRAVENOUS, 1 MG | $35,301 | $30,006 | — | — | 24 |
| 06118177_1 | INJECTION, LANREOTIDE, 1 MG | $34,423 | $29,260 | — | — | 24 |
| 06118199_1 | INJECTION, IPILIMUMAB, 1 MG | $31,958 | $27,164 | — | — | 24 |
| 06118197_1 | INJECTION, VEDOLIZUMAB, INTRAVENOUS, 1 MG | $31,200 | $26,520 | — | — | 24 |
| 06118188_1 | INJECTION, OBINUTUZUMAB, 10 MG | $31,006 | $26,355 | — | — | 24 |
| 06118277_1 | INJECTION, LURBINECTEDIN, 0.1 MG | $28,620 | $24,327 | — | — | 24 |
| 06118212_1 | INJECTION, NIVOLUMAB, 1 MG | $28,034 | $23,829 | — | — | 24 |
| 06118322_1 | INJECTION, ATEZOLIZUMAB, 10 MG | $26,727 | $22,718 | — | — | 24 |
| 06118162_1 | INJECTION, RAMUCIRUMAB, 5 MG | $26,223 | $22,290 | — | — | 24 |
| 06118305_1 | INJECTION, IMMUNE GLOBULIN (PRIVIGEN), INTRAVENOUS, NON-LYOPHILIZED (E.G., LIQUID), 500 MG | $25,336 | $21,536 | — | — | 24 |
| 06118121_1 | INJECTION, OCTREOTIDE, DEPOT FORM FOR INTRAMUSCULAR INJECTION, 1 MG | $23,919 | $20,331 | — | — | 24 |
| 06118183_1 | INJECTION, PERTUZUMAB, 1 MG | $23,496 | $19,972 | — | — | 24 |
| 06118095_1 | LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG | $23,180 | $19,703 | — | — | 24 |
| 06118180_1 | INJECTION, PEGFILGRASTIM, EXCLUDES BIOSIMILAR, 0.5 MG | $23,105 | $19,639 | — | — | 24 |
| 07852528_1 | INJECTION, TENECTEPLASE, 1 MG | $22,450 | $19,083 | — | — | 24 |
| 06118190_1 | INJECTION, PEMBROLIZUMAB, 1 MG | $21,232 | $18,047 | — | — | 24 |
| 04550472_1 | CONNECTIVE TISSUE, HUMAN (INCLUDES FASCIA LATA) | $20,014 | $17,012 | — | — | 24 |
| 06118187_1 | INJECTION, RASBURICASE, 0.5 MG | $19,341 | $16,440 | — | — | 24 |
| 06118168_1 | INJECTION, ROMIPLOSTIM, 10 MICROGRAMS | $17,172 | $14,596 | — | — | 24 |
| 06118093_1 | INJECTION, RITUXIMAB, 10 MG | $16,912 | $14,375 | — | — | 24 |
| 06118218_1 | INJECTION, BASILIXIMAB, 20 MG | $16,366 | $13,911 | — | — | 24 |
| 04863650_1 | Insertion of spinal neurostimulator electrode array through skin | $16,308 | $13,862 | — | — | 24 |
| 04863663_1 | Revision of spinal neurostimulator electrode array using fluoroscopic guidance | $16,308 | $13,862 | — | — | 24 |
| 07862005_1 | NF-ANIMAS INSULIN PUMP R1000 | $16,250 | $13,813 | — | — | 22 |
| 07863180_1 | NF-Animas Insulin Pump R1000 | $16,250 | $13,813 | — | — | 22 |
| 06118114_1 | INJECTION, OCTREOTIDE, DEPOT FORM FOR INTRAMUSCULAR INJECTION, 1 MG | $15,973 | $13,577 | — | — | 24 |
| 04862350_1 | Insertion, revision, or repositioning of spinal canal tube for medication administration | $15,884 | $13,501 | — | — | 24 |
| 04862365_1 | Removal of spinal canal drug infusion pump or device | $15,884 | $13,501 | — | — | 24 |
| 06118310_1 | INJECTION, IMMUNE GLOBULIN, (OCTAGAM), INTRAVENOUS, NON-LYOPHILIZED (E.G., LIQUID), 500 MG | $15,861 | $13,482 | — | — | 24 |
| 07852425_1 | INJECTION, ALTEPLASE RECOMBINANT, 1 MG | $15,841 | $13,465 | — | — | 24 |
| 06118287_1 | INJECTION, RITUXIMAB-ABBS, BIOSIMILAR, (TRUXIMA), 10 MG | $15,220 | $12,937 | — | — | 24 |
| 06118221_1 | INJECTION, DURVALUMAB, 10 MG | $15,158 | $12,884 | — | — | 24 |
| 06118250_1 | INJECTION, PEGFILGRASTIM-CBQV (UDENYCA), BIOSIMILAR, 0.5 MG | $15,030 | $12,776 | — | — | 24 |
| 06118321_1 | INJECTION, PEGFILGRASTIM-CBQV (UDENYCA), BIOSIMILAR, 0.5 MG | $15,030 | $12,776 | — | — | 24 |
| 06118298_1 | INJECTION, ENFORTUMAB VEDOTIN-EJFV, 0.25 MG | $14,872 | $12,641 | — | — | 24 |
Showing top 50 of 8,899 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.